Amneal launches generic abiraterone acetate tablets, usp, 500 mg, following anda approval by fda

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) announced that it has received approval of an additional strength of 500 mg to its abbreviated new drug application (anda), from the u.s. food and drug administration (fda) for abiraterone acetate tablets, usp, 250 mg and 500 mg. this anda is approved for its use in combination with prednisone. abiraterone acetate tablets, usp, 250 mg and 500 mg, are the generic version of zytiga® for treat
AMRX Ratings Summary
AMRX Quant Ranking